0001179110-19-008316.txt : 20190702
0001179110-19-008316.hdr.sgml : 20190702
20190702133947
ACCESSION NUMBER: 0001179110-19-008316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190702
DATE AS OF CHANGE: 20190702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Enyedy Mark J
CENTRAL INDEX KEY: 0001586965
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 19936408
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOGEN INC
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
edgar.xml
FORM 4 -
X0306
4
2019-07-01
0
0000855654
IMMUNOGEN INC
IMGN
0001586965
Enyedy Mark J
24 CONCORD SQUARE
BOSTON
MA
02118
1
1
0
0
Chief Executive Officer
Common Stock
2019-07-01
4
A
0
5230
1.84
A
488998
D
These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from January 1, 2019 through June 30, 2019.
In accordance with the ESPP; these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2019.
/s/ Craig Barrows, attorney in fact
2019-07-02